Rio Piedras, Puerto Rico Clinical Trials

A listing of Rio Piedras, Puerto Rico clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 224 clinical trials
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia

This clinical trial studies how well simplified patient care strategy works in decreasing early death in patients with acute promyelocytic leukemia. Implementing simplified acute promyelocytic leukemia guidelines along with support from acute promyelocytic leukemia experts may decrease deaths and improve survival.

tretinoin
Centro Comprensivo de Cancer de UPR
 (1.8 away) Contact site
  • 144 views
  • 15 Mar, 2021
  • +221 other locations
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors

This research trial studies saliva, semen, and blood samples to determine effects of chemotherapy on fertility in osteosarcoma survivors. Study biospecimen samples from osteosarcoma survivors in the laboratory may help doctors learn whether chemotherapy causes fertility problems and to learn more about the long term effects.

cancer
cancer chemotherapy
San Jorge Children's Hospital
 (4.1 away) Contact site
  • 1970 views
  • 28 Jul, 2021
  • +72 other locations
Stress and Treatment Response in Puerto Rican Children With Asthma

This study aims to first determine whether high child stress leads to reduced response to common treatmenIs for asthma (inhaled corticosteroids and short-acting bronchodilators), and then to identify DNA methylation differences leading to stress-induced treatment resistance among children with asthma.

Behavioral Sciences Research Institute, University of Puerto Rico
 (6.8 away) Contact site
  • 7 views
  • 12 Apr, 2021
  • +1 other locations
CemiplimAb Survivorship Epidemiology

The objectives of the study are: To describe the effectiveness of cemiplimab 350 mg administered every 3 weeks (Q3W) for treatment of patients with advanced CSCC in real-world clinical settings To evaluate the safety of cemiplimab based on incidence of treatment related immune-related adverse events (irAEs), infusion related reactions (IRRs), …

cemiplimab
exposure to radiation
Regeneron Research Facility
 (1.8 away) Contact site
  • 28 views
  • 26 Jan, 2021
  • +43 other locations